1. Home
  2. BPRN vs NGNE Comparison

BPRN vs NGNE Comparison

Compare BPRN & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPRN
  • NGNE
  • Stock Information
  • Founded
  • BPRN 2007
  • NGNE 2003
  • Country
  • BPRN United States
  • NGNE United States
  • Employees
  • BPRN N/A
  • NGNE N/A
  • Industry
  • BPRN Major Banks
  • NGNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • BPRN Finance
  • NGNE Health Care
  • Exchange
  • BPRN Nasdaq
  • NGNE Nasdaq
  • Market Cap
  • BPRN 216.1M
  • NGNE 251.9M
  • IPO Year
  • BPRN N/A
  • NGNE N/A
  • Fundamental
  • Price
  • BPRN $29.45
  • NGNE $17.86
  • Analyst Decision
  • BPRN Strong Buy
  • NGNE Strong Buy
  • Analyst Count
  • BPRN 1
  • NGNE 7
  • Target Price
  • BPRN $35.00
  • NGNE $41.86
  • AVG Volume (30 Days)
  • BPRN 10.2K
  • NGNE 186.5K
  • Earning Date
  • BPRN 07-24-2025
  • NGNE 08-08-2025
  • Dividend Yield
  • BPRN 4.08%
  • NGNE N/A
  • EPS Growth
  • BPRN N/A
  • NGNE N/A
  • EPS
  • BPRN 1.67
  • NGNE N/A
  • Revenue
  • BPRN $73,010,000.00
  • NGNE $925,000.00
  • Revenue This Year
  • BPRN $14.19
  • NGNE N/A
  • Revenue Next Year
  • BPRN $15.48
  • NGNE N/A
  • P/E Ratio
  • BPRN $17.66
  • NGNE N/A
  • Revenue Growth
  • BPRN 6.10
  • NGNE N/A
  • 52 Week Low
  • BPRN $27.25
  • NGNE $6.88
  • 52 Week High
  • BPRN $39.35
  • NGNE $74.49
  • Technical
  • Relative Strength Index (RSI)
  • BPRN 42.02
  • NGNE 48.91
  • Support Level
  • BPRN $30.06
  • NGNE $18.22
  • Resistance Level
  • BPRN $29.75
  • NGNE $21.43
  • Average True Range (ATR)
  • BPRN 0.52
  • NGNE 2.15
  • MACD
  • BPRN -0.15
  • NGNE -0.45
  • Stochastic Oscillator
  • BPRN 18.04
  • NGNE 19.98

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: